National Health Investors, Inc.
NYSE:NHIREIT - Healthcare Facilities
-$0.30 today
- Market cap
- $3.07B
- Beta
- 0.55
- P/E (TTM)
- 22.9
- EPS (TTM)
- $3.07
- Dividend yield
- 5.21%
Volume 0.74M
Average 0.40M
NHI EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
National Health Investors, Inc.NYSE: NHI
EBITDA · Q3 FY2026 · quarter ended Sep 2026
EBITDA growth accelerates
Q3 FY2026 EBITDA of $601.09M rose 813.5% year over year, ahead of the +205.9% change in trailing-twelve-month EBITDA. Sequentially, it rose 516.8% from the prior quarter. Over 3 fiscal years it compounded at +16.4% a year.
Context
- EBITDA amounted to 74.5% of revenue in FY2025, down 4.3 pp from a year earlier.
- EBITDA increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether next quarter's EBITDA reaches the consensus estimate of $79.37M, a +7.9% change from the same quarter last year.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $601.09M+516.8% QoQ
- Last fiscal yearDec 2025
- $282M+6.8% YoY
- LTMSep 2026
- $851.29M+205.9% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +813.5% | +7.9% | -805.6 pp |
| 1 year | +6.8% | — | — |
| 3-year CAGR | +16.4% | -1.6% | -18.0 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 282M USD
- Year-over-year change
- +6.8%
- 4-year CAGR
- +4.0%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 282M | +6.8% |
| FY2024 | 2024-12-31 | 264.16M | +1.7% |
| FY2023 | 2023-12-31 | 259.87M | +45.4% |
| FY2022 | 2022-12-31 | 178.73M | -25.8% |
| FY2021 | 2021-12-31 | 240.94M | — |
EBITDA vs competitors
How NHI compares with its peers on the latest reported figures
- NHI's LTM Sep 2026 EBITDA of $851.29M is the 3rd highest of the 9 companies compared; the peer median is $488.48M.
- Its year-over-year change of +205.9% is the highest of 9, against a peer median of -4.5%.
- EBITDA amounts to 186.2% of revenue for NHI, versus a peer median of 61.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $3.4B | +1.7% | -15.6% | 67.6% | |
| LTM Mar 2026 | $881.1M | -19.9% | -3.3% | 72.9% | |
| LTM Sep 2026 | $851.29M | +205.9% | +16.4% | 186.2% | |
| LTM Jun 2026 | $585.32M | +23.4% | +7.6% | 80.1% | |
| LTM Sep 2026 | $550M | -10.8% | -17.7% | 5.0% | |
| LTM Jun 2026 | $426.96M | +9.0% | +5.0% | 54.4% | |
| LTM Jun 2026 | $423.61M | +16.5% | +2.2% | 88.6% | |
| LTM Sep 2026 | $409.35M | -77.0% | +61.0% | 22.2% | |
| LTM Jun 2026 | $390.9M | -17.8% | +28.2% | 45.5% | |
| Peer median (excluding NHI) | $488.48M | -4.5% | +3.6% | 61.0% | |
Competitors are the stored peer set for NHI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 298.72M | 278.19M | 319.84M | 335.18M | 378.53M |
| Cost of Revenue | 11.64M | 9.79M | 11.51M | 11.17M | 239.6M |
| Gross Profit | 287.08M | 268.41M | 308.32M | 324.02M | 138.93M |
| Gross Margin | 96.1% | 96.5% | 96.4% | 96.7% | 36.7% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 19.34M | 25.32M | 19.82M | 21.79M | 0 |
| Operating Expenses | 101.83M | 135.64M | 129.53M | 140.16M | (55.9M) |
| Depreciation & Amortization | 80.8M | 70.88M | 69.97M | 71.44M | 83.85M |
| EBITDA | 240.94M | 178.73M | 259.87M | 264.16M | 282M |
| EBITDA Margin | 80.7% | 64.2% | 81.3% | 78.8% | 74.5% |
| Operating Income | 185.25M | 132.77M | 178.79M | 183.86M | 194.83M |
| Operating Margin | 62.0% | 47.7% | 55.9% | 54.9% | 51.5% |
| Interest Income | 0 | 0 | (2.65M) | 0 | 23.82M |
| Interest Expense | 48.11M | 42.44M | 55.51M | 56.12M | 57.37M |
| Other Income / Expenses | (73.22M) | (67.35M) | (44.41M) | (47.26M) | (54.04M) |
| Income Before Tax | 112.03M | 65.41M | 134.38M | 136.59M | 140.79M |
| Pre-Tax Margin | 37.5% | 23.5% | 42.0% | 40.8% | 37.2% |
| Income Tax Expense | 66K | (89K) | 0 | (45K) | 0 |
| Net Income | 111.8M | 66.4M | 135.65M | 137.99M | 142.18M |
| Net Margin | 37.4% | 23.9% | 42.4% | 41.2% | 37.6% |
| EPS (Basic) | 1.36 | 0.52 | 3.13 | 3.14 | 3.03 |
| EPS (Diluted) | 1.36 | 0.51 | 3.13 | 3.13 | 3.02 |
| Weighted Avg Shares | 45.71M | 44.77M | 43.39M | 43.85M | 46.88M |
| Weighted Avg Shares (Diluted) | 45.73M | 44.79M | 43.39M | 44.1M | 47.05M |
National Health Investors, Inc.
NYSE:NHI
Intrinsic Alpha fair value
Locked
Current Price
$62.43
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.